Gene · 873
Papers2,488
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,488
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breaking immune evasion in breast cancer by targeting COX-2/PGE2 pathway. | Mol Cell Endocrinol | 2025 | 40712694 | PubTator, text mining | PubMed |
| Mechanism of 15-hydroxyprostaglandin dehydrogenase protein inhibiting cervical cancer cell proliferation through downregulation of the notch1 signaling pathway. | Cytojournal | 2025 | 40708835 | PubTator, text mining | PubMed |
| GPM6B inhibits tumor progression by targeting HPGD in lung adenocarcinoma. | Mol Med Rep | 2025 | 40641109 | PubTator, text mining | PubMed |
| Various anthracyclines exhibit differential cytotoxic effects related to CBR1-induced resistance in lung cancer cells. | Med Oncol | 2025 | 40629205 | PubTator, text mining | PubMed |
| The joint role of the immune microenvironment and N7-methylguanosine for prognosis prediction and targeted therapy in acute myeloid leukemia. | Front Genet | 2025 | 40584831 | PubTator, text mining | PubMed |
| Prediction of successful labor induction using 15-hydroxyprostaglandin dehydrogenase in cervicovaginal fluid. | Am J Obstet Gynecol | 2025 | 40543795 | PubTator, text mining | PubMed |
| IGF2BP2 regulates inflammation in ulcerative colitis through N6-methyladenosine-dependent modulation of CBR1. | Int Immunopharmacol | 2025 | 40526983 | PubTator, text mining | PubMed |
A Comprehensive Study of the Synthesis, Spectral Characteristics, Quantum-Chemical Molecular Electron Density Theory, and In Silico Future Perspective of Novel CBr3-Functionalyzed Nitro-2-Isoxazolines Obtained via (3 + 2) Cycloaddition of (E)-3,3,3-Tribromo-1-Nitroprop-1-ene. | Molecules | 2025 | 40430322 | PubTator, text mining | PubMed |
The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele-Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization. | Pharmacol Res Perspect | 2025 | 40405401 | PubTator, text mining | PubMed |
| Drugs Metabolism-Related Genes Variants Impact on Anthracycline-Based Chemotherapy Induced Subclinical Cardiotoxicity in Breast Cancer Patients. | Int J Mol Sci | 2025 | 40362292 | PubTator, text mining | PubMed |
| A KAN-based hybrid deep neural networks for accurate identification of transcription factor binding sites. | PLoS One | 2025 | 40334196 | PubTator, text mining | PubMed |
| SNP's use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic. | Funct Integr Genomics | 2025 | 40261508 | PubTator, text mining | PubMed |
Influence of Polymorphisms in Pharmacokinetics-Related Genes on the Areas Under the Plasma Concentration-Time Curves of Doxorubicin and Doxorubicinol in Patients with Diffuse Large B-Cell Lymphoma Receiving CHOP Therapy. | Eur J Drug Metab Pharmacokinet | 2025 | 40186087 | PubTator, text mining | PubMed |
| Human skeletal muscle possesses both reversible proteomic signatures and a retained proteomic memory after repeated resistance training. | J Physiol | 2025 | 40183698 | PubTator, text mining | PubMed |
| CBR-Net: A Multisensory Emotional Electroencephalography (EEG)-Based Personal Identification Model with Olfactory-Enhanced Video Stimulation. | Bioengineering (Basel) | 2025 | 40150774 | PubTator, text mining | PubMed |
| Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson's disease. | Acta Neuropathol Commun | 2025 | 40122840 | PubTator, text mining | PubMed |
| Tumor Regulatory Effect of 15-Hydroxyprostaglandin Dehydrogenase (HPGD) in Triple-Negative Breast Cancer. | Int J Mol Sci | 2025 | 40076539 | PubTator, text mining | PubMed |
| A Case Study of a Female Infant With Primary Hypertrophic Osteoarthropathy Demonstrates That Early Initiation of Celecoxib Slows but Does Not Prevent Symptom Progression. | Am J Med Genet A | 2025 | 39840454 | PubTator, text mining | PubMed |
| Lactylation modulation identifies key biomarkers and therapeutic targets in KMT2A-rearranged AML. | Sci Rep | 2025 | 39789150 | PubTator, text mining | PubMed |
| Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism. | Nat Commun | 2025 | 39788955 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/873/papers?page=4